113 related articles for article (PubMed ID: 6894679)
1. [Treatment of Grave's disease by radio iodine. Observation of 277 patients (author's transl)].
San Marco JL; Tobiana F; Dupin B; Simonin R
Ann Endocrinol (Paris); 1980; 41(6):597-600. PubMed ID: 6894679
[TBL] [Abstract][Full Text] [Related]
2. [The utilization of small repeated doses of iodine 131 in the treatment of Graves' disease. Results (author's transl)].
Latapie JL; Lefort G; Commenges M; Roger P; Riviere LJ; Mauriac L
Ann Endocrinol (Paris); 1980; 41(6):601-5. PubMed ID: 6894680
[TBL] [Abstract][Full Text] [Related]
3. [The treatment of Graves' disease with antithyroid drugs and small doses of radioiodine (author's transl)].
Jafiol C; Baldet L; Papachristou C; Lavit C; Mirouze J
Ann Endocrinol (Paris); 1980; 41(6):593-6. PubMed ID: 6166243
[TBL] [Abstract][Full Text] [Related]
4. Relevance of cause of hyperthyroidism in determining its management.
Veneman TF; Weymer M; Tjabbes T; van Haeften TW
Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
[TBL] [Abstract][Full Text] [Related]
5. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
[TBL] [Abstract][Full Text] [Related]
7. Cordocentesis to predict fetal outcome after administration of radio-active iodine for Graves' disease.
Calderwood C; Williams H; Campbell IW; Toft AD; Cameron A
J Obstet Gynaecol; 2002 Mar; 22(2):217-8. PubMed ID: 12521713
[No Abstract] [Full Text] [Related]
8. [Prognostic evolution of Graves' disease. Surgical treatment (author's transl)].
Putelat R; Brun JM; Ferry C; Lalloue C
Ann Endocrinol (Paris); 1980; 41(6):606-10. PubMed ID: 6894681
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
[TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of influential factors correlating with early and late hypothyroidism after (131)I therapy for Graves' disease.
Wang RF; Tan J; Zhang GZ; Meng ZW; Zheng W
Chin Med J (Engl); 2010 Jun; 123(12):1528-32. PubMed ID: 20819506
[TBL] [Abstract][Full Text] [Related]
13. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
15. [Long term effects of the treatment of the Graves' disease by 4 different therapeutics (author's transl)].
Mornex R; Quintana J; Chavrier B
Ann Endocrinol (Paris); 1977; 38(4):273-82. PubMed ID: 578399
[TBL] [Abstract][Full Text] [Related]
16. [Hyperthyroidism in children (author's transl)].
Lorini R; Larizza D; Bozzola M; Livieri C; Cisternino M; Salvatoni A; Severi F
Pediatr Med Chir; 1981; 3(1):41-4. PubMed ID: 6170957
[TBL] [Abstract][Full Text] [Related]
17. Outcome following radioactive iodine therapy in Graves' disease.
Chen JY; Huang HS; Huang MJ; Lin JD; Juang JH; Huang BY; Wang PW; Liu RT
Changgeng Yi Xue Za Zhi; 1990 Dec; 13(4):258-67. PubMed ID: 2282562
[TBL] [Abstract][Full Text] [Related]
18. The early development of transient and permanent hypothyroidism following radioiodine therapy for hyperthyroid Graves' disease.
Peden NR; Hart IR
Can Med Assoc J; 1984 May; 130(9):1141-4. PubMed ID: 6546895
[TBL] [Abstract][Full Text] [Related]
19. Transient hypothyroidism after iodine-131 therapy for Grave's disease.
Gómez N; Gómez JM; Orti A; Gavaldà L; Villabona C; Leyes P; Soler J
J Nucl Med; 1995 Sep; 36(9):1539-42. PubMed ID: 7658207
[TBL] [Abstract][Full Text] [Related]
20. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
